Northpointe Capital’s SYNERGETICS USA, INC. SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-902,904
Closed -$5.93M 178
2015
Q3
$5.93M Sell
902,904
-727,377
-45% -$3.78M 0.77% 46
2015
Q2
$7.66M Buy
1,630,281
+453,681
+39% +$2.2M 0.9% 36
2015
Q1
$6.34M Sell
1,176,600
-75,925
-6% -$359K 0.69% 40
2014
Q4
$5.45M Buy
1,252,525
+373,953
+43% +$1.34M 0.65% 48
2014
Q3
$3M Buy
878,572
+113,465
+15% +$354K 0.32% 94
2014
Q2
$2.37M Buy
765,107
+223
+0% +$736 0.23% 124
2014
Q1
$2.33M Buy
764,884
+95,344
+14% +$323K 0.24% 100
2013
Q4
$2.42M Buy
669,540
+405,260
+153% +$1.66M 0.21% 103
2013
Q3
$1.2M Buy
264,280
+96,852
+58% +$402K 0.14% 157
2013
Q2
$660K Buy
+167,428
New +$552K 0.08% 161

Northpointe Capital's SURG Position: Q4 2015 in Review

Northpointe Capital sold out of SYNERGETICS USA, INC. (SURG) in Q4 2015, closing a stake of 902,904 shares — an estimated $5.93M sold.

Northpointe Capital first reported a position in SURG in Q2 2013 and held it in 10 quarters. The position peaked at $7.66M in Q2 2015. 0 funds tracked by Wall St. Rank hold SURG as of Q4 2015.

  • Northpointe Capital reported no remaining SYNERGETICS USA, INC. position as of Q4 2015 after selling out during the quarter.
  • Northpointe Capital sold 902,904 SYNERGETICS USA, INC. shares in Q4 2015, an estimated $5.93M.
  • Northpointe Capital first reported a position in SYNERGETICS USA, INC. in Q2 2013 and held it in 10 quarters.
  • Northpointe Capital's SYNERGETICS USA, INC. position peaked at $7.66M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SYNERGETICS USA, INC. as of Q4 2015.

Based on Northpointe Capital's 13F filing for Q4 2015, filed 28 Jan 2016.